co

ACS Career Days program brings career resources to the community

Society hosts professional development events in cities across the US




co

Sanofi, BARDA team for coronavirus vaccine




co

Porous ionic liquid captures alcohols and CFCs

Cage-like structures could enable selective separations in continuous-flow systems




co

45Q, the tax credit that's luring US companies to capture CO<sub>2</sub>

Cement, ethanol, and ammonia makers are among those looking to convert waste carbon to cash




co

Trichloroethylene poses risks to workers and consumers, EPA says

Draft assessment confirms previous concerns about health effects of chlorinated solvent




co

Chemical firms see light at end of coronavirus tunnel

Facilities are reopening in China but spread of virus outside China is raising concerns




co

Gilead and Moderna lead on coronavirus treatments

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine




co

TPC faces consequences for Texas explosion

The company will need years to rebuild and is being sued by the state




co

China's new place on the front lines of diagnosing and treating coronavirus disease

Industry watchers say the effort is unprecedented and would not have been possible during the last SARS outbreak




co

Genetic signature links bacterial toxin to colon cancer

Colibactin causes key cancer mutations




co

Faulty probes are to blame for CDC coronavirus testing woes

The tests can still be used, CDC says, as urgency over possible outbreak grows




co

Coronavirus cancels chemical events

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on




co

Trichloroethylene poses risks to workers and consumers, EPA says

Draft assessment confirms concerns about health effects of chlorinated solvent




co

Gilead buys immuno-oncology-focused Forty Seven

The $4.9 billion deal adds a mid-stage cancer drug to the big biotech's pipeline




co

Pittcon goes ahead despite coronavirus concerns

Product launches and champagne toasts at instrumentation conference bely worries about infection




co

Faulty probes are to blame for CDC coronavirus testing woes

Early batches of the test can still be used, CDC says, while affirming it will deploy new kits




co

$8.3 billion allocated for US coronavirus response

Congress opts for open-ended support for federal and local agencies




co

Researchers in China report structure of the novel coronavirus bound to its human target

The structure shows the first steps of SARS-CoV-2 infection, and could help in drug discovery




co

ACS Strategic Plan highlights recent accomplishments




co

Coronavirus cancels chemical events

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on




co

Gilead and Moderna lead on coronavirus treatments

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine




co

Pittcon goes ahead despite coronavirus

Product launches and champagne toasts belied worries about infection




co

Genetic signature links bacterial toxin to colon cancer

Colibactin causes key cancer mutations




co

Actinide orbitals drive C–C coupling

Reaction creates actinide 2-metallabiphenylenes




co

Gold coating helps illuminate hosiery

Electrodes made from pantyhose are the basis of light-emitting fabrics that can stretch and change display patterns




co

Photocatalyst converts fatty acids to diesel and jet-fuel molecules selectively

Method provides petroleum-free way to turn industrial biowaste into valuable commodity




co

DSM to acquire human milk oligosaccharide firm Glycom




co

Cristina Sáenz de Pipaón wants to put CO<sub>2</sub> to good use

Her company, Orchestra Scientific, is developing membrane technology to separate carbon dioxide from other gases and use it as a product




co

Erika Milczek is replacing banned chemicals in consumer products

With Curie Co., the entrepreneur designs alternatives to compounds like parabens that have fallen out of favor with retailers




co

Mariana Matus means to combat the opioid epidemic with chemical data

Her company, Biobot Analytics, is analyzing wastewater to give communities the information they need for the battle




co

Paula Hammond on women in science: Life will always be busy; start a company anyway

The MIT chemical engineering head is charting a course into the start-up world with LayerBio




co

After launching 7 companies in 12 years, Carolyn Bertozzi says she's not slowing down

Prolific biotech business founder says she's always on the lookout for problem-solving opportunities




co

Frances Arnold on founding a company: ‘Building the right teams is critical'

Nobel Prize winner wants to solve real-world problems with directed evolution




co

Gilead y Moderna lideran los tratamientos contra el coronavirus

Gilead toma ventaja gracias a un antiviral, mientras que Moderna está buscando una nueva vacuna ARNm.




co

Chemists work around coronavirus restrictions

C&EN looks at how scientists are adapting to travel restrictions and working from home




co

Coronavirus forces cancellations of scientific meetings

Spring lineup of conferences and events frequented by chemists is slashed




co

Podcast: How the coronavirus could disrupt the drug supply

Hear what C&EN's pharmaceutical editors have learned about how the coronavirus is affecting drug production in China and across the globe




co

One-pot process converts CO<sub>2</sub> captured from the air into methanol

Scientists use an alkali hydroxide–based system to turn carbon dioxide into a carbon-neutral fuel




co

Coronavirus hits Europe

Chemical makers brace for a slowdown on the continent




co

Can old drugs take down a new coronavirus?

Several approved and well-studied small molecules could be repurposed as treatments for COVID-19




co

Finding comets' hidden nitrogen

Ammonium salts may serve as nitrogen reservoirs on the icy bodies, suggesting a common origin for comets and the sun




co

How COVID-19 is changing my graduate school experience




co

How we know disinfectants should kill the COVID-19 coronavirus

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2–specific data are lacking




co

Gates, Wellcome, and Mastercard give $125 million for coronavirus treatments




co

Corbion plans more lactic acid




co

$8.3 billion allocated for US coronavirus response

Congress opts for open-ended support for federal and local agencies




co

Chemists work around coronavirus restrictions

C&EN looks at how scientists are working from home and adapting to travel restrictions




co

Researchers in China report structure of the novel coronavirus bound to its human target

The structure shows the first steps of SARS-CoV-2 infection and could help in drug discovery




co

How one country is grappling with mercury emissions from artisanal gold shops

Peru seeks to keep rudimentary gold refining from exposing communities to neurotoxic metal




co

As telecom demands grow, optical fibers will need to level up

Scientists explore how to revamp the hair-thin silica glass fibers to transmit more and more data